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 Episodes of amplitude and frequency co-modulation occur in the high-gamma frequency band
between hemispheres in patients with Parkinson’s disease.
 Co-modulation is spontaneous and can be independent of voluntary movement.
 Co-modulation occurs without phase delay between the hemispheres and may reﬂect shifts in
arousal.
a b s t r a c t
Objective: Dopaminergic treatment of patients with Parkinson’s disease can be associated with a ﬁnely
tuned high-gamma (FTG) band oscillation between 60 and 90 Hz in the basal ganglia (BG) nuclei. This
activity, together with suppression of excessive neural synchrony in the beta frequency band (15–
30 Hz), is hypothesized to contribute to the pro-kinetic effects of dopaminergic medication. Beta activity,
which high-gamma replaces, has been shown to be bilaterally coherent, but whether sub-cortical FTG
activity is in some way linked across hemispheres remains unknown.
Methods: We analyse bilateral local ﬁeld potential activity recorded from the subthalamic nuclei of 10
patients on dopaminergic medication while at rest, following surgery for deep brain stimulation.
Results: In three of these patients FTG activities were coherent across the hemispheres. Short duration
(618 s) bilateral amplitude and frequency co-modulation were recorded in all subjects, although the
two phenomena were independent in time and independent of similar episodes in other frequency bands.
Conclusions: FTG co-modulation can be independent of movement and of co-modulation episodes at
other frequencies.
Signiﬁcance: Relatively independent organisation of processing through amplitude and frequency modu-
lation within different frequency bands potentially affords opportunities for functional segregation and
multiplexing of processing streams within the BG.
 2013 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd.
Open access under CC BY license.1. Introduction
Use of functional neurosurgery for treatment of movement dis-
orders such as Parkinson’s disease (PD) has made exploration and
characterisation of basal ganglia (BG) pathophysiology possible
(Hammond et al., 2007). Single unit neuronal and local ﬁeld poten-
tial (LFP) activities can be captured from electrodes implanted in
BG surgical targets like the subthalamic nucleus (STN) and globus
pallidus. Such recordings have been invaluable in the characterisa-
tion of human BG activity during different medication and behav-
ioural states (Jenkinson and Brown, 2011).Loss of dopamine in the substantia nigra pars compacta of pa-
tients with PD is associated with excessive synchronization of neu-
ral activity in the beta frequency band (15–30 Hz). This excessive
activity is coherent ipsilaterally across the BG and between the
BG and ipsilateral motor cortex (Brown et al., 2001; Marsden
et al., 2001). Additionally, it is coherent between the two STNs,
when patients with PD are withdrawn from their dopaminergic
medication and are recorded at rest (de Solages et al., 2010).
When PD patients are administered dopaminergic medication,
excessive beta synchrony is reduced and synchronization of neural
activity at higher frequencies is observed, for example as ﬁnely
tuned peaks between 60 and 90 Hz in the high-gamma frequency
band (FTG) (Fig. 1) (Brown, 2003; Brown et al., 2001). It has been
suggested that this high-gamma activity is pro-kinetic, particularly
Fig. 1. Log normalized LFP power spectral density for all subjects from the three DBS contact pairs 0–1, 1–2, and 2–3, left and right STN. Contact pair analysed for each subject
is indicated in the title.
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(Androulidakis et al., 2007a; Cassidy et al., 2002; Kühn et al.,
2006a). However, it remains unknown whether bilateral coherence
observed in the beta frequency band in the STN extends to other
frequency bands such as the high-gamma frequency band after
dopaminergic treatment, and, if it does, what its function might
be. Here, we address this question through the analysis of LFP
activity recorded bilaterally from the subthalamic nuclei of pa-
tients with PD undergoing surgery for deep brain stimulation
(DBS).
2. Methods
2.1. Patients and LFP recordings
All patients gave their informed consent to take part in the
study, which was approved by the local ethics committees at our
recording sites in London, Rome and Berlin. Our aim was to test
the independence or otherwise of discrete high-gamma band peaks
in the LFPs, recorded at rest bilaterally from the two STNs. We thusscreened archival data from 25 PD patients who had undergone
bilateral implantation of DBS electrodes into the STN, as a prelude
to therapeutic high frequency stimulation for advanced idiopathic
PD with motor ﬂuctuations and/or dyskinesias. Only data obtained
while patients were on levodopa (L-DOPA) was considered so as to
maximise the incidence and amplitude of the high-gamma band
activity (Alegre et al., 2005; Alonso-Frech et al., 2006; Androulida-
kis et al., 2007a; Brown et al., 2001; Cassidy et al., 2002; Devos
et al., 2006; Fogelson et al., 2005). We identiﬁed recordings from
10 patients with bilateral discrete high-gamma band peaks for fur-
ther analysis (Fig. 1 and Table 1). Techniques to target and implant
electrodes in the STN have previously been described Foltynie and
Hariz (2010). Microelectrode recordings were made during surgery
in Rome and Berlin. The permanent quadripolar macroelectrode
used was model 3389 (Medtronic Neurologic Division, Minneapo-
lis, MN, USA) featuring four platinum-iridium cylindrical surfaces.
Its contacts are numbered 0, 1, 2, and 3, with 0 being the most cau-
dal and contact 3 being the most cranial. Localisation was sup-
ported intra-operatively by microelectrode recordings in two
centres, the effects of direct stimulation and by immediate post-
Table 1
Patient information on age, gender, disease duration, symptoms, and UPDRS scores. Total L-DOPA equivalent dose was estimated according to (Tomlinson et al., 2010). Case 1 was
operated at the National Hospital for Neurology and Neurosurgery in London, Cases 2 and 3 were operated at the Centro Traumatologico Ortopedico, A. Alesini Hospital, in Rome,
and cases 4–10 were operated on at the Charité, Berlin. Data obtained from subject 1 has been previously published in (Fogelson et al., 2005), subject 4 in (Kühn et al., 2006b),
subject 6 in (Doyle et al., 2005; Kühn et al., 2006a,b), subject 7 in (Kühn et al., 2009), and subject 10 in (Kühn et al., 2006a,b, 2009; Trottenberg et al., 2006).
Age/
gender
Disease duration
(years)
More
affected side
Predominant symptoms Pre-op UPDRS
OFF/ON
Post-op UPDRS – DBS OFF/ON
(while OFF med)
Total L-DOPA equivalent
dose/day (mg)
1 46/m 13 Right Dyskinesias on 63/08 61/21 1990
2 54/f 6 Right Dyskinesias on 48/29 46/31 1320
3 59/f 13 Left Dyskinesias on 27/08 26/13 300
4 51/m 6 Left On–off ﬂuctuations,
Dyskinesia on
40/15 35/22 1320
5 67/f 12 Right Bradykinesia off, Dyskinesias
on, Freezing
57/29 N/A 1370
6 62/f 12 Right Bradykinesia off, Dyskinesias
on
51/16 54/25 1080
7 79/m 7 Right Bradykinesia off, Tremor off 30/07 30/14 540
8 57/f 7 Right Wearing off 33/13 35/19 510
9 69/m 16 Left Tremor 47/26 30/14 1000
10 57/m 17 Left Tremor 39/18 44/8 600
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were externalized through the scalp to enable recordings prior to
connection to a subcutaneous DBS pacemaker, implanted in a sec-
ond operative procedure up to seven days later. Mean percentage
improvement in the motor section of the Uniﬁed Parkinson’s Dis-
ease Rating Scale (UPDRS; (Fahn and Elton,1987)) on treatment
with L-DOPA was 61 ± (SD) 15% (p < 0.001, paired t-test between
ON and OFF L-DOPA scores), indicating very good responsiveness
to L-DOPA by our study participants, while improvement in the
motor section of the UPDRS off L-DOPA, on DBS was 50 ± (SD)
11% with respect to off L-DOPA, off DBS (p < 0.0025, paired t-test
between ON and OFF DBS scores), supporting satisfactory DBS elec-
trode placement.
LFP recordings were made 3–6 days after surgery. Recordings
were made on average 60 min following L-DOPA administration,
after overnight withdrawal of anti-parkinsonian medication. L-
DOPA dosage was the same as the patients’ usual ﬁrst morning
dose (median dose 200 mg, range 100–300 mg). Improvement with
medication was conﬁrmed through assessment of ﬁnger tapping,
wrist rigidity and tremor (using the corresponding items of the
motor UPDRS). Subjects rested in a chair with their eyes open. They
were asked to remain quiet and still, and rest was conﬁrmed by vi-
sual inspection. Periods of dyskinesia, tremor or voluntary move-
ment detected by the examiner on visual inspection were noted
and excluded from further analysis. LFPs were recorded bipolarly
from each DBS electrode as contact pairs 0–1, 1–2, and 2–3. Signals
were band-pass ﬁltered between 1 and 250 Hz. Signals were
ampliﬁed (50,000) and digitised in two ways: (1) In nine cases
(Rome and Berlin) we used a custom-made, 9 V battery-operated
high-impedance ampliﬁer (INA128 instrumentation ampliﬁer,
Texas Instruments, Inc., Dallas, TX, USA). These signals were sam-
pled at 1 kHz (with two exceptions which were at 526 and
625 Hz). They were either digitised through a 1401 A/D converter
(Cambridge Electronic Design, Cambridge, UK) onto a computer
using Spike2 software (Cambridge Electronic Design; 8 cases in
Berlin) or through an A-D card (PCM-DAS16S; Computer Boards,
Massachusetts, USA; 2 cases in Rome) onto a portable computer
using custom written software. (2) One subject (London; case 1)
was recorded using a D360 ampliﬁer (Digitimer Ltd, Welwyn Gar-
den City, Hertfordshire, UK), sampled at 2 kHz and recorded
through a 1401 A/D converter onto a computer using Spike2 soft-
ware. Given the differences in recording techniques we only con-
trasted normalised measures (coherence and correlation) and not
absolute power levels in later analysis. 238 ± [SEM] 50 s of data
were available for analysis in each patient.2.2. Data analysis and statistics
LFP recordings were analysed ofﬂine using MATLAB. All record-
ings were down-sampled to 512 Hz and ﬁltered using a sixth order
notch ﬁlter with a pass-band ripple of 1 dB in order to suppress
50 Hz power line artifact.2.2.1. Power spectral analysis
Power spectral density was calculated using short-time Fourier
transform with a Hamming window of 1 s and 75% overlap.2.2.2. Contact pair selection
An expert neurosurgeon or neurologist specialising in deep
brain stimulation who was blinded to the electrophysiological re-
sults determined which electrode contacts were in the STN from
post-operative MRI. This afforded up to three bipolar contacts that
had at least one contact within the STN per electrode (13 STN with
two bipolar pairs and 5 STN with three bipolar pairs). From these
contact pairs we then selected the one exhibiting the highest gam-
ma (60–90 Hz) power for further analysis, as this provides further
evidence that at least one of the contacts lies in STN (Fogelson
et al., 2005; Trottenberg et al., 2006). The post-operative MRI
was unavailable in case 9, so we took the contact pair with the
highest gamma power, as before. Only one channel per electrode
was subsequently analysed in terms of cross-hemisphere co-mod-
ulation, regardless of the frequency band of interest (Fig. 1).2.2.3. Coherence
Coherence between bilateral LFP recordings was estimated
using Welch’s averaged modiﬁed periodogram method with non-
overlapping Hamming windows (Rabiner and Gold, 1975; Welch,
1967). Window length was set to 1 s giving rise to a frequency res-
olution of 1 Hz. The threshold for signiﬁcant coherence (p = 0.05)
was determined using a method based on surrogate time series.
For each side, 1000 surrogate time series were generated by com-
puting the Fourier Transform of the original time series, resam-
pling phase without replacement while keeping the modulus of
the time series unchanged and applying the inverse Fourier trans-
form in order to return to the time domain. Coherence was then
estimated between the bilateral surrogate time series and the
threshold for signiﬁcant coherence was set at 95th percentile of
the coherence values obtained from the surrogate pairs.
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The LFP was pass-band ﬁltered in both the forward and reverse
directions, to achieve zero phase distortion, using a tenth order
Butterworth ﬁlter with a pass band of ±5 Hz around the average
FTG peak frequency. If the FTG peak frequencies were more than
1 Hz apart on the two sides the ﬁlter’s pass-band window was cho-
sen so that both peaks were included in a 10 Hz wide pass-band.
The amplitude-envelope and instantaneous frequency of the ﬁl-
tered time series were estimated using the Hilbert Transform of
the signal. The amplitude envelope of the FTG oscillation was com-
puted using:
AðxÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
x tð Þ2 þ H xðtÞð Þ2
q
where x(t) is the pass-band ﬁltered time series and H(x(t)) is the Hil-
bert Transform of the pass-band ﬁltered time series. The instanta-
neous frequency of the FTG oscillation was computed by
differentiating the unwrapped phase of the analytic signal con-
structed from the Hilbert Transform of the pass-band ﬁltered time
series (real part of the analytic signal is equivalent to x(t) and the
imaginary part of the analytic signal is equivalent to the Hilbert
Transform of x(t)). Instantaneous phase of the analytic signal was
obtained using:
/ tð Þ ¼ arctan HðxðtÞÞ; xðtÞð Þ
Bilateral co-modulation of the amplitude-envelopes and instan-
taneous frequencies in the high-gamma band was estimated by
computing the maximum cross-correlation level between bilateral
amplitude-envelopes and bilateral instantaneous frequencies over
1 s long 87.5% overlapping windows. If the maximum cross corre-
lation occurred at a lag greater than 30 ms or less than 30 ms, the
cross-correlation level was set to zero, so as to focus on relatively
direct interactions between the two STNs and the effects of bilater-
ally synchronous inputs. Relaxing the limit on lags to ±150 ms
made less than 3% difference in amplitude-envelope and instanta-
neous frequency co-modulation (results not shown). Threshold for
signiﬁcant cross-correlation was calculated utilizing a method
based on surrogate time series. For each side, 1000 surrogate time
series were generated by computing the Fourier Transform of the
original time series, resampling phase without replacement while
keeping the modulus of the time series unchanged and applying
the inverse Fourier transform to return to the time domain. The
amplitude-envelope and instantaneous frequency of the shufﬂed
time series were calculated as before. Threshold for signiﬁcant cor-
relation was set at the 95th percentile of the cross-correlation val-
ues obtained from bilateral amplitude-envelopes or instantaneous
frequencies of the surrogate pairs.2.2.5. FTG co-modulation dependence on other frequency bands
In order to test whether co-modulation of amplitude-envelopes
and instantaneous frequency in the high-gamma band was depen-
dent on bilateral changes in other frequency bands, we calculated
the number of time segments with amplitude or frequency co-
modulation in the high-gamma band, which also contained co-
modulation of amplitude or frequency in the theta/alpha band
(4–14 Hz), the beta band (15–30 Hz) or the low-gamma band
(31–48 Hz) (Fig. 1). Signiﬁcance of these coincidence rates was
tested by shufﬂing the 1 s long time segments 1000 times, and
computing the number of shufﬂed time segments with amplitude
or frequency co-modulation in the high-gamma band, which also
contained co-modulation of amplitude or frequency in other fre-
quency bands (theta/alpha, beta, low gamma frequency bands)
and assessing whether coincidence rates lied within or outside
95th percentile of the shufﬂed series.3. Results
All 10 PD subjects had bilateral discrete peaks in the high-gam-
ma frequency band in power spectra of STN-LFPs simultaneously
recorded in the ON L-DOPA state. Bilateral STN FTG oscillations
were signiﬁcantly coherent in only three out of the ten cases
(p 6 0.05; unpaired one-sided t-test; subjects 7, 8 and 10;
Fig. 2A–C) despite the peak FTG frequency being the same in 5 sub-
jects (Table 2). Four of the subjects demonstrated coherence in the
theta/alpha frequency band (p 6 0.05; unpaired one-sided t-test;
subjects 5, 6, 9 and 10) and only one of the subjects demonstrated
coherence in the beta band in the ON state (p 6 0.05; unpaired
one-sided t-test; subject 10). None of the subjects demonstrated
coherence in the low-gamma band in the ON state (p > 0.05; un-
paired one-sided t-test).3.1. Bilateral FTG amplitude and frequency co-modulation
We investigated whether the amplitude envelopes or instanta-
neous frequencies of the STN FTG oscillations were correlated
bilaterally (Figs. 2 and 3). On average, 7.4% of each recording
showed signiﬁcant correlation of high-gamma band amplitude-
envelopes across the hemispheres (p 6 0.05; unpaired one-sided
t-test) with an average lag of 0 s. These short duration bilateral
co-modulations of the amplitude-envelopes could last up to 18 s
(Fig. 4). Additionally, signiﬁcant correlation of the instantaneous
frequency of the STN FTG oscillations across the hemispheres
was observed with an average lag of 0 s for an average of 8.1% of
each recording (p 6 0.05; unpaired one-sided t-test).
Co-modulation of the instantaneous frequencies could last up to
15 s. Bilateral co-modulation of amplitude envelopes and instanta-
neous frequency did not coincide in time above chance level for
any subject.3.2. Bilateral amplitude and frequency co-modulation in other
frequency bands
For comparison, we also investigated whether the amplitude
envelope or instantaneous frequency of STN theta/alpha (4–
14 Hz), beta (15–30 Hz) and low gamma (31–48 Hz) oscillations
were correlated bilaterally. The amplitude envelopes of theta/al-
pha oscillations were signiﬁcantly correlated across the hemi-
spheres on average 9.7 ± 1.4% of the recording time (p 6 0.05;
unpaired one-sided t-test) with an average lag of 0 s (Table 3),
whereas the instantaneous frequency of the STN theta/alpha oscil-
lations was correlated across the two hemispheres on average
7 ± 0.7% of the recording time (p 6 0.05; unpaired one-sided t-test)
with an average lag of 0 s (Table 3). Co-modulation of amplitude
and frequency in the theta/alpha frequency band coincided in time.
The amplitude envelopes of beta oscillations were also signiﬁ-
cantly correlated across the hemispheres on average 7.8 ± 1.2% of
each recording (p 6 0.05; unpaired one-sided t-test; average
lag = 0 s) (Table 3); and the beta instantaneous frequency was cor-
related on average 5.3 ± 0.9% of each recording across the two
hemispheres (p 6 0.05; unpaired one-sided t-test; average
lag = 0.002 s) (Table 3).
Amplitude envelopes of low gamma oscillations were signiﬁ-
cantly correlated across hemispheres on average 5.7 ± 0.7% of
each recording (p 6 0.05; unpaired one-sided t-test) with an aver-
age lag of 0 s (Table 3). There were no discrete peaks in power in
the low-gamma frequency range therefore it was not possible to
investigate instantaneous frequency co-modulation in this fre-
quency band.
Fig. 2. Co-modulation of amplitude envelope and instantaneous frequency in subject 8. (A and B) Log normalized STN LFP power spectrum in the high-gamma band from the
left and right STN, respectively. (C) Signiﬁcant coherence between the left and right STN in the high-gamma band; dotted red line depicts the threshold for coherence set to
the 95th percentile of the surrogate dataset. (D and E) Example changes in the amplitude envelope of STN high-gamma oscillations in the left and right STN, respectively. (F)
Corresponding signiﬁcant correlation between amplitude envelope changes. (G and H) Example changes in the instantaneous frequency of STN high-gamma oscillations in
the left and right STN, respectively. (I) Corresponding signiﬁcant correlation between instantaneous frequency changes. Correlated segments are highlighted using red
vertical lines in D, E, G and H. In F and I, signiﬁcance is determined according to the 95th percentile of the corresponding correlation levels derived from the surrogate dataset.
(For interpretation of color in this Figure, the reader is referred to the web version of this article.)
Table 2
Peak theta/alpha, beta and FTG frequencies in the left and right STN: In 5/10 subjects, peak FTG frequency was the same across the hemispheres. FTG activity was coherent across
hemispheres in cases 7, 8 and 10.
Peak alpha/theta frequency Peak beta frequency Peak FTG frequency
Left STN Right STN Left STN Right STN Left STN Right STN
1 5 Hz / 24 Hz / 74 Hz 74 Hz
2 / / 26 Hz 25 Hz 72 Hz 71 Hz
3 / 11 Hz / 17 Hz 69 Hz 65 Hz
4 / / / / 74 Hz 71 Hz
5 9 Hz / 27 Hz / 89 Hz 84 Hz
6 / / 25 Hz 24 Hz 79 Hz 79 Hz
7 / / 16 Hz 16 Hz 81 Hz 81 Hz
8 / 7 Hz 27 Hz 25 Hz 81 Hz 81 Hz
9 8 Hz 8 Hz 16 Hz 16 Hz 78 Hz 80 Hz
10 11 Hz 10 Hz 25 Hz / 85 Hz 85 Hz
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bands
In addition, we studied whether bilateral co-modulation of the
amplitude of STN FTG oscillations coincided with bilateral co-mod-
ulation of the amplitude of STN beta oscillations. In 10/10 cases,
co-modulation of the amplitude of STN FTG oscillations did not oc-
cur at the same time with co-modulation of the amplitude of STN
beta oscillations (p 6 0.05; unpaired one-sided t-test). Similarly,
co-modulation of the frequency of STN FTG oscillations did not oc-
cur at the same time with co-modulation of the frequency of STNbeta oscillations (p 6 0.05; unpaired one-sided t-test). Further-
more, co-modulation of the amplitude or instantaneous frequency
of STN FTG oscillations did not coincide with co-modulation in the
theta/alpha band (4–14 Hz) or those in the low-gamma frequency
band (p 6 0.05; unpaired one-sided t-test).
4. Discussion
We have shown that there is co-modulation of FTG oscillations
in the STN of the two hemispheres in patients with PD. This could
take the form of amplitude co-modulation, frequency co-modula-
Fig. 3. Co-modulation of amplitude envelope and instantaneous frequency in subject 2. (A and B) Log normalized STN LFP power spectrum in the high-gamma band from the
left and right STN, respectively. (C) There is no coherence between the left and right STN in the high-gamma band; dotted red line depicts the threshold for coherence set to
the 95th percentile of the surrogate dataset. (D and E) Example changes in the amplitude envelope of STN high-gamma oscillations in the left and right STN, respectively. (F)
Corresponding signiﬁcant correlation between amplitude envelope changes. (G and H) Example changes in the instantaneous frequency of STN high-gamma oscillations in
the left and right STN, respectively. (I) Corresponding signiﬁcant correlation between instantaneous frequency changes. Correlated segments are highlighted using red
vertical lines in D, E, G and H. In F and I, signiﬁcance is determined according to the 95th percentile of the corresponding correlation levels derived from the surrogate dataset.
(For interpretation of color in this Figure, the reader is referred to the web version of this article.)
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co-modulation, and, in three patients, cotemporous amplitude
and phase co-modulation implied by coherence. Co-modulation
was truly synchronised, with mean temporal differences of zero
milliseconds between sides. Anatomical evidence for direct con-
nectivity between the two STNs is lacking in the primate (Carpen-
ter and Strominger, 1967; Carpenter et al., 1981), although limited
activity in the contralateral STN can be evoked at very short-la-
tency by stimulation of the ipsilateral nucleus, possibly through
stimulation of ﬁbres of passage (Brun et al., 2012; Walker et al.,
2011). The bulk of modulatory effects of stimulation of one STN
upon the other are of much longer latency than the temporal dif-
ference between STNs reported here, and are compatible with indi-
rect communication between the two STNs (Brun et al., 2012).
Thus our ﬁndings suggest one or more bilateral common inputs
to the two STN that modulate FTG activities across the hemi-
spheres more-or-less simultaneously. The simplest explanation
for such common input would be that linked to voluntary move-
ment, which in PD can be associated with bilateral (albeit greater
contra-laterally) amplitude increases in FTG, although bilateral fre-
quency modulation has not been previously reported (Androulida-
kis et al., 2007a; Cassidy et al., 2002). However, our recordings
were made with patients at rest. Furthermore, although voluntary
movements are associated with a phasic reciprocal change in the
high-gamma and beta bands, we found FTG co-modulationepisodes to be isolated, and more prolonged than those observed
with voluntary movement (Androulidakis et al., 2007a; Cassidy
et al., 2002).
Could co-modulation of FTG be related to concurrent dyskine-
sias, given that six of the subjects had symptomatic dyskinesias
prior to the operation? Subtle dyskinesias may have been missed
during the recordings, but the relationship of this involuntary
movement to FTG is unclear. Fogelson et al. (2005) related dyskine-
sias to FTG activity, but only in the presence of reciprocal changes
in beta activity. The latter were missing in the current study. Other
authors have suggested that dyskinesias relate to theta/alpha
power rather than FTG activity (Alegre et al., 2012; Alonso-Frech
et al., 2006; Rodriguez-Oroz et al., 2011). Bilateral changes in
amplitude envelope and instantaneous frequency in the alpha/the-
ta frequency band were not present during co-modulation of
amplitude or instantaneous frequency in the high-gamma fre-
quency band.
Equally, could co-modulation of FTG be related to concurrent
tremor, given that three of the subjects had symptomatic tremor
prior to the operation? Subtle rest tremor may have been missed
by visual inspection during the recordings. However, there are no
reports relating the presence or character of FTG (over 60–90 Hz)
to residual rest tremor in the ON medication state, although one
study has detailed a relationship between rest tremor and LFP
power in the contra-lateral STN over a lower gamma frequency
Fig. 4. Group data for likelihood of a given duration of co-modulation of the envelopes of amplitude (A–C) and instantaneous frequency (D–F) of bilateral theta/alpha (A:
amplitude co-modulation D: frequency co-modulation), beta (B: amplitude co-modulation E: frequency co-modulation) and high-gamma oscillations (C: amplitude co-
modulation F: frequency co-modulation). DurationsP2 s imply thatP2 one-second periods are contiguous and signiﬁcant. Bins marked with  indicate contiguous durations
which are signiﬁcantly different from those that could occur at random (p 6 0.05; unpaired one-sided t-test).
Table 3
Average lag (seconds) and incidence rate of signiﬁcant bilateral co-modulation of amplitude envelopes and instantaneous frequency in the theta/alpha, beta, low and high gamma
frequency bands.
Theta amplitude Theta frequency Beta amplitude Beta frequency
Incidence (%) Average lag (s) Incidence (%) Average lag (s) Incidence (%) Average lag (s) Incidence (%) Average lag (s)
1 7.4 0.002 6.8 0 4.35 0.002 3.7 0.006
2 17.5 0.002 10.4 0.002 7.2 0.004 6.2 0
3 4.9 0.01 3.2 0.012 6.9 0 2 0.006
4 17.7 0 8.2 0 12.5 0 5.3 0.002
5 8.9 0 7 0.002 6.9 0 5 0
6 7.5 0 3.5 0 6.7 0 5.2 0
7 8.6 0.002 9.4 0.004 5 0.002 3.1 0.002
8 6.2 0 7.8 0 5.7 0 6.9 0
9 6.4 0 5.7 0.002 16.7 0.004 12 0.004
10 11.4 0.002 7.6 0 5.9 0.002 4 0
Average 9.7 ± 1.4 0 ± 0.002 7 ± 0.7 0 ± 0.002 7.8 ± 1.2 0 ± 0.002 5.3 ± 0.9 0.002 ± 0.002
Low Gamma amplitude High gamma amplitude High gamma frequency
Incidence (%) Average lag (s) Incidence (%) Average lag (s) Incidence (%) Average lag (s)
1 6.1 0 7.6 0 10.8 0
2 7.5 0 14 0.002 14.7 0
3 4.6 0.002 3.9 0 14.7 0
4 10.3 0 8.9 -0.002 4.9 0
5 5.6 0 6.6 0 5.6 0
6 4.2 0 9.1 0 12.2 0
7 3.1 0.004 7.7 0.002 4.7 0.002
8 5.9 0.002 6.9 0.002 5.4 0
9 5.4 0.004 5 0.004 4 0.004
10 3.9 0.002 4.4 0.002 4.3 0.004
Average 5.7 ± 0.7 0 ± 0.002 7.4 ± 0.9 0 ± 0.002 8.1 ± 1.4 0 ± 0.002
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tion did not coincide with low-gamma co-modulation. In the pres-
ent study although two of the three cases with bilateral FTG
coherence had symptomatic tremor, including one case with tre-
mor-dominant PD, the other patient with tremor-dominant PD,
did not have bilateral FTG coherence.
Another event associated with bilateral amplitude co-modula-
tion in FTG is arousal, as elicited by startling auditory stimuli or
as occurring spontaneously in REM sleep (Kempf et al., 2009). Re-
lated to this, FTG is known to be suppressed during drowsiness
(Brown et al., 2001). Thus the relatively prolonged co-modulation
across the hemispheres shown here could be due to spontaneous
ﬂuctuations in arousal (Jenkinson et al., 2013). If so, then these
ﬂuctuations were subtle enough not to manifest clinically,
although subliminal variations in arousal (or the related phenom-
enon of vigilance) have long been believed to be responsible for
ﬂuctuations in performance measures like reaction time (Lansing
et al., 1959). Indeed, a correlation has recently been reported be-
tween high-gamma levels in the thalamus prior to imperative cues
and subsequent reaction time (Brücke et al., 2013). A link with
arousal does not preclude further more marked changes in FTG
that are more speciﬁcally related to movement and which tend
to be more lateralised (Androulidakis et al., 2007a; Brücke et al.,
2008).
If co-modulation of FTG at rest relates to minor ﬂuctuations in
arousal then which pathways may mediate these effects? Projec-
tions from the cerebral cortex are unlikely drivers, as FTG in the
STN drives (phase-leads) rather than is driven by cortical activity
(Lalo et al., 2008; Litvak et al., 2012; Williams et al., 2002). Perhaps
more likely is the possibility that high-gamma is bilaterally modu-
lated by the ascending reticular activating system, including the
pedunculopontine nucleus (Jenkinson et al., 2009; Pahapill and
Lozano, 2000), either directly or via the non-speciﬁc nuclei of the
thalamus (Sadikot et al., 1992).
In order to maximise our ability to track variation in the ampli-
tude and frequency of the FTG we opted to assess PD patients after
treatment with dopaminergic medication including L-DOPA, as FTG
is more prominent in this state (Alegre et al., 2005; Alonso-Frech
et al., 2006; Androulidakis et al., 2007a; Brown et al., 2001; Cassidy
et al., 2002; Devos et al., 2006; Fogelson et al., 2005). This, how-
ever, may account for the relative lack of co-modulation and coher-
ence of beta activity across the hemispheres in our patient cohort
compared to recordings made off L-DOPA (de Solages et al., 2010).
Dopaminergic treatment suppresses beta activity and may also
promote its reactivity and lateralisation (Androulidakis et al.,
2007b). In contrast, beta activity tends to be bilaterally coherent
(show amplitude and phase covariation) in patients withdrawn
from antiparkinsonian medication (de Solages et al., 2010). In four
out of 10 subjects we also observed signiﬁcant coherence in the
theta/alpha frequency band despite lack of discrete theta/alpha
oscillations as evidenced by a peak in this frequency band.
Another factor that might have contributed to the relative
sparseness of cross-hemisphere co-modulation and coherence is
the possibility of a stun effect in our post-operative recordings.
This can attenuate LFP activity in the beta frequency band (Chen
et al., 2006), but little, if anything, is known about its effects on
FTG or on cross-hemisphere coupling.
Although we recorded FTG in the STN of patients with PD, this
activity is by no means disease speciﬁc, having also been reported
in patients with essential tremor, dystonia and myoclonic epilepsy
(Kempf et al., 2009). Moreover, FTG is likely seen throughout the
BG, having been found in recordings from the thalamus, globus
pallidus interna (GPi) and STN (Alegre et al., 2012; Alonso-Frech
et al., 2006; Androulidakis et al., 2007b; Brown et al., 2001; Cassidy
et al., 2002; Devos et al., 2006; Fogelson et al., 2006; Kempf et al.,
2009; López-Azcárate et al., 2010; Pogosyan et al., 2006; Trotten-berg et al., 2006; Williams et al., 2002). These observations lead
to speculation that the FTG may be an essentially physiological,
possibly arousal related, phenomenon.
Finally, the temporal independence of co-modulations in high-
gamma frequency and amplitude, and of these and amplitude
and frequency co-modulation in the theta/alpha, beta and low-
gamma bands supports the idea that synchronisation at different
frequencies could provide a means of functionally segregating pro-
cessing streams that may then be multiplexed in the motor system
(Fogelson et al., 2006). Furthermore, it allows for the relatively
independent organisation of processing through amplitude and
frequency modulation of on-going oscillations (Foffani et al.,
2005). Whether these multiple dimensions of information carrying
capacity are actually utilised deserves further investigation.
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